Copyright
©2014 Baishideng Publishing Group Inc.
World J Cardiol. Aug 26, 2014; 6(8): 802-813
Published online Aug 26, 2014. doi: 10.4330/wjc.v6.i8.802
Published online Aug 26, 2014. doi: 10.4330/wjc.v6.i8.802
Ref. | Study population | Study type/country | Silent ischemia% | Conclusion |
Arenja et al[36] | 1621 pts in the derivation cohort + 338 pts in the validation cohort | Derivation cohort/ Switzerland | 23.3%- 28.5% in DM and 21.5% in non-DM | DM is an independent predictor for the presence of SMI (OR = 1.5; 95%CI: 1.1-1.9, P = 0.004). In the validation cohort, the prevalence of SMI = 26.3% (n = 89), while the prevalencea in diabetics (35.8%) vs non-diabetics was 24% (P = 0.049) |
Sheikh et al[37] | 200 subjects, 31 diabetics vs 169 non-diabetics | A cross-sectional study/Pakistan | (19%) diabetics vs (13%) non-diabetics | No significant difference in the frequency of SMI in diabetics vs non-diabetics |
Peña et al[38] | 220 asymptomatic NIDDM patients | A prospective, observational, analytical study /Havana | 29.10% | Type 2 diabetics with ischemia had ↑ levels of total cholesterol, LDL and triglycerides. HDL levels were significantly reducedb. The association of ↓ HDL with ↑ triglycerides was a strong indicator of SMI in NIDDM patients |
Ruano Pérez et al[39] | 56 asymptomatic diabetics | retrospective study | 46.40% | Moderate-severe ischemia in 10.7%, necrosis with ischemia in 5.4% and necrosis in 7.1%, diabetic nephropathy was the only factor related to an abnormal SPECT (P = 0.043) |
Blanchet Deverly et al[40] | 147 NIDDM patients | cross-sectional study /France | 23.10% | Multivariate logistic-regression analyses, the adjusted OR of SMI significantly ↑ in patients with a history of cardiovascular disease (4.36, 95%CI: 1.36-13.96, P = 0.01) and LVH (2.46, 95%CI: 1.03-5.86, P = 0.04) |
Mbaye et al[41] | 79 diabetics | Prospective/France | 67.10% | Predominance of motion abnormalities in the anterior territory (83%). Cardiovascular risk factors associated with positivity of the test were microalbuminuria (P = 0.0001), inactivity (P = 0.0001), dyslipidemia (P = 0.0002), arterial hypertension (P = 0.001), smoking (0.003) and male sex (P = 0.004) |
Bansal et al42] | 1123 NIDDM patients | Prospective/Detection of Ischemia in Asymptomatic Diabetics ( DIAD) /United States and Canada (DIAD) study | 21%-24% in the intermediate high risk group 19%-23% in the low risk group | Cardiac event ratesa in intermediate/high-risk. The annual cardiac event rate was ≤ 1% in all risk groups. In intermediate-/high-risk participants randomized to screening vs no screening, 4.8-yr cardiac event rates were similar (2.5%-4.8% vs 3.1%-3.7%) |
Agarwal et al[43] | 77 NIDDM | Prospective study/India | 28.90% | The prevalence of SMI similar in males and females. Serum LDL levels > 140 mg % had a significant correlation with the prevalence of silent CAD (P = 0.04). The difference in CCA-IMT values was found to be statistically significant between the silent CAD and non-CAD groups (P = 0.019) |
Ugur-Altun et al[44] | 90 asymptomatic NIDDM patients | Prospective/Turkey | 4% | Diabetics with SMI had ↑ fibrinogen level (372 ± 51 mg/dL vs 307 ± 71 mg/dL, P = 0.04), had b total exercise time and peak workload (375 ± 30 s vs 474 ± 115 s, P = 0.04; 7.3 ± 0.5 vs 8.9 ± 1.9, P = 0.04, respectively) |
Chico et al[47] | 353 NIDDM asymptomatic Caucasians | Prospective/Spain | 8.50% | SMI patients were older, had ↑ prevalence of autonomic neuropathy, microalbuminuria, hypertension, and dyslipidemia than those without |
Wackers et al[48] | 1123 NIDDM patients | Prospective/United States | 20% | Predictors for abnormal tests: abnormal Valsalva, male sex and diabetes duration (5.2). Traditional cardiac risk factors or inflammatory and prothrombotic markers were not predictive. Ischemic adenosine-induced ST-segment depression with normal perfusion in women |
Falcone et al[50] | 618 patients with CAD | Prospective/Italy | 58% | SMI during exercise seen in 58% of diabetics and 64% of nondiabetics. Both diabetics and non-diabetics with exertional SMI had ↑ heart rate values (P < 0.01), SBP (P < 0.01), rate-pressure product (P < 0.001), work load (P < 0.01) and maximum ST depression at peak exercise (P < 0.05) |
Coisne et al [51] | 49 diabetics and 63 non-diabetics | Prospective/France | 9% | Significant CAD detected in 9% of asymptomatic diabetics. Dynamic left ventricular obstruction observed in 59% of the diabetic population and in only 22% in the non-diabetic population |
Sukhija et al[53] | 30 diabetics/30 non diabetics | Prospective/India | 46.70% | Diabetics had ↑ heart rate and a greater number of supraventricular and ventricular ectopics, aprevalence of multi-vessel involvement and diffuse disease compared to controls. 50% of diabetics and none of the controls had autonomic dysfunction. Autonomic dysfunction was present in 85.7% of diabetics with SMI vs 18.7% of diabetics without SMI (P = 0.001) |
May et al[54] | 240 diabetics | Prospective/Denmark | 13.50% | Frequency of SMI did not differ significantly between diabetics and non-diabetics. Systolic blood pressure was predictive of SMI in diabetes |
Tamez-Pérez et al[55] | 60 NIDDM patients | Prospective/ Spain | 17% | In a 2-yr follow-up, 4 diabetics developed symptomatic angina pectoris |
Ahluwalia et al[56] | 20 male diabetics | Prospective/India | 50% | On exercise testing in diabetics, SMI was detected in 64% of the patients with 3 vessel disease, 50% of the patients with 2 vessel disease and 20% of the patients with one-vessel disease vs 18% of non-diabetic patients with three-vessel disease (P < 0.05) and in none of the patients with two- or one-vessel disease |
Tanaka et al[61] | 92 NIDDM patients | Prospective / Japan | 38% | Diabetics with positive treadmill test were smokers, and had hypertension and ↑ triglyceride level compared to treadmill negative diabetics |
Nesto et al[62] | 30 diabetics with peripheral vascular disease | Prospective /United States | 57% | 57% had thallium abnormalities, with reversible thallium defects compatible with ischemia in 47% and evidence of prior, clinical SMI in 37%. Thallium abnormalities were seen more frequently in diabetics with concomitant hypertension and cigarette smoking (P = 0.001) |
Koistinen et al[63] | 136 diabetic subjects | Controlled study/ Finland | 29% | Coronary angiography of 34 diabetics; 12 had significant coronary artery narrowing; seven had unimportant atherosclerosis; 15 had patent coronary arteries |
Theron et al[64] | 52 IDDM and 87 NIDDM subjects | Prospective /South Africa | See conclusion | No statistically significant relationship between any parameter and the presence of autonomic neuropathy. Atypical infarctions not limited to subjects with autonomic neuropathy, the incidence mucha than the general population |
Touze et al[65] | 50 black African diabetics | Prospective /Africa | 10% | SMI was ↓ among black African diabetics compared with white diabetics. The coronary lesions were mostly limited. Proximal narrowing and one-vessel disease mostly encountered- |
Ref. | Study population/ | Study type/country | Atypical presentation % | Conclusion |
Stern et al[68] | 2113 ACS patients | Nationwide survey/Israel | 21.7% had no chest pain | In multivariate analysis, variables associated with no anginal pain/atypical symptoms on presentation (ina order): history of heart failure, age, no past angina, diabetes and non-smoking. 18.7% of male patients had no chest pain on presentation vs 29.7% of females |
Culić et al[69] | 1996 MI patients | A prospective, observational study/Croatia | 14.8% had no chest pain | The independent predictors of atypical presentation in both gender; alevels of CK-MB fraction (P < 0.0001 and P = 0.0003, respectively), NIDDM (P = 0.0002 and P = 0.002, respectively), older age (P = 0.001 and P = 0.01, respectively), and no smoking in men (P = 0.005) The independent predictors of the presence of non-pain symptoms; DM (P = 0.048 and P = 0.005, respectively), alevels of CK-MB (P = 0.01 and P = 0.049, respectively) and hypercholesterolemia (P =0.01) in both men and women |
Hwang et al[70] | 931 newly diagnosed as ACS | Retrospective/ South Korea | 7.8% of younger pts and 13.4% of older pts | A logistic regression analysis after adjustment for gender and ACS type indicated that diabetes and hyperlipidemia significantly predicted atypical symptoms in younger patients |
MacKenzie et al[71] | 64 (12 women with DM) | Descriptive, cross-sectional/Canada | See conclusion | Less chest pain in diabetics vs non-diabetics (P = 0.02) No difference in pain intensity in diabetics with MI vs non-diabetics (P≥ 0.05) Diabetics with UA or MI were more likely to report mid-sternal chest pain (P = 0.04) and chest pain that radiated to the back of the left arm (P = 0.01) than non-diabetics Diabetics with UA or MI reported more SOB (53.1% vs 31.3%; NS) In diabetics with UA or MI, SOB was a factor in deciding to seek care |
Coronado et al[72] | 2541 (1058 women, 410 women with DM); | Secondary analysis of multisite a prospective clinical trial/United States | 6.2% of patients with ACS and in 9.8% of AMI. | DM independent predictor of painless presentation in acute MI, but not in the ACS group. Diabetes more common in non-pain ACS (35% vs 26%; P = 0.01) Shortness of breath most common in the painless presentation group (72%) and women were more likely to have painless ACS (53%) (P = 0.007) |
Vaccarino et al[73] | 384878 patients | Prospective, observational study/ National Registry of MI/United States | 33% | Atypical presentation patient: older, ↑ proportion of women and diabetics without a significant interaction between sex and diabetes (P = 0.30). HF comorbidities and less likely to have coronary intervention with bchance of anticoagulants, aspirin and β blocker usage |
Canto et al[74] | 434877 MI ptsJune 1994-March 1998 | Prospective observational study United States | 33% had no chest pain | Patients without chest pain on presentation: Likely to be diabetics (32.6% vs 25. 4%) Older (74.2 yr vs 66.9 yr). Likely to be female (49.0% vs 38.0%) Likely to have prior HF (26.4% vs 12.3%)Had a longer delay before hospital presentation (mean, 7.9 h vs 5.3 h) Less likely to be diagnosed with confirmed MI at the time of admission (22.2% vs 50.3%) Less likely to receive thrombolysis or PCI (25.3% vs 74.0%), aspirin (60.4% vs 84.5%), BB (28.0% vs 48.0%), or heparin (53.4% vs 83.2%). 23.3% in-hospital mortality vs 9.3% in patients with chest pain |
Medalie et al[75] | 9509 healthy adult subjects | Israeli Heart Attack study, cohort/ Israel | 3.6 unrecognized MI/ 1000 persons and 5.3 clinical MI/1000 persons | By multivariate analysis, age, left axis deviation, LVH, cigarette smoking, systolic or diastolic BP, and PVD were the most significant risk factors. Cholesterol, DM, anxiety, and psychosocial problems, do not play a significant role in unrecognized MI |
Brieger et al[76] | 20881 ACS patients | Global Registry of Acute Coronary Events/multinational, prospective, observational study (in 14 countries) | 8.4% presented without chest pain | 23.8% not initially recognized as having an ACS, < 33% of the population with atypical symptoms were diabetics. Less likely to receive effective cardiac medications ahospital morbidity and mortality (13% vs 4.3%, respectively; P < 0.0001) ahospital mortality rates in patients with presenting symptoms of pre-syncope/syncope. Nausea or vomiting, dyspnea and in those with painless presentations of UA |
Ref. | Study population/ | Study type/country | Atypical presentation % | Conclusion |
Meshack et al[77] | 589 patients, aged 25 to 74 yr, with AMI | A community-based surveillance program/ United States | Sweating (64.2%), fatigue (62.6%), dyspnea (60.3%), and arm or jaw pain (58.2%). | Adjusting for age, DM, gender, and relative to non-Hispanic whites, Mexican Americans were more likely to report chest pain, upper back pain, and palpitations, and less likely to report arm or jaw pain |
Richman et al[78] | 216 (19 women with DM); AMI | A prospective, observational study/United States | No statistical difference in diabetics vs non-diabetics in terms of the presence chest pain | No difference in the frequency of chest pain or associated symptoms by diabetic status (P≥ 0.05) -no chest pain symptoms was more common in diabetic patients (NS) |
Kentsch et al[79] | 1042 (330 women; 155 women with DM) with STEMI | Secondary analysis of MITRA PLUS (18786 pts.; North German Registry, NGR, 1042 pts.)/ Germany | 16.9% of DM and 15.0% of non-DM | No difference in the frequency or intensity of chest pain by diabetic status Patients with DM reported significantly more dyspnea than those without DM (29.5% vs 19.5%; P < 0.01) |
DeVon et al[80] | 100 (50 women, 23 women with DM); DM | rospective secondary analysis; descriptive, cross-sectional; structured interview/United States | 3% | No difference in the frequency and severity of chest pain in diabetics vs non-diabetics (P ≥ 0.05) No differences in UA symptoms by diabetic status Patients with DM reported weakness as the second most common symptom and more likely to describe chest pain as squeezing (P = 0.02) or aching (P = 0.04) than non-diabetics Diabetics had ↑ frequency of hyperventilation (P = 0.04) and afrequency of nausea (P = 0.04) than non-diabetics |
Thuresson et al[81] | N = 1939 (480 women, 82 women with DM) | Descriptive, cross-sectional study/Sweden | See conclusion | No difference in chest pain or other ACS symptoms by DM status Women reported more tiredness/weakness, anxiety/fear, vomiting, back pain, left arm pain and neck or jaw pain than men (P = 0.01). |
- Citation: Khafaji HAH, Suwaidi JMA. Atypical presentation of acute and chronic coronary artery disease in diabetics. World J Cardiol 2014; 6(8): 802-813
- URL: https://www.wjgnet.com/1949-8462/full/v6/i8/802.htm
- DOI: https://dx.doi.org/10.4330/wjc.v6.i8.802